Wartość prognostyczna badania patomorfologicznego w rakach nerki
14. Klopper G, Knofel WF, Bausch H: Prognostic of renal cell carcinoma related to nuclear grade, DNA content and Robson stage. Euro Urol 1996; 12: 42631. 15. Cheville JC, Blute ML, Zincke H i wsp.: Stage pT1 conventional (clear cell) renal cell carcinoma. Pathological features associated with cancer specific survival. J Urol 2001; 166: 453-56. 16. Zisman A, Pautuch AJ, Chao D i wsp.: Reevoluation of the 1997 TNM Classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm better correlates with clinical outcome. J Urol 2001; 166: 54-58. 17. Medeiros LJ, Gelb AB, Weiss LM: Renal cell carcinoma. Prognostics significance of morphologic parameters in 121 cases. Cancer 1988; 61: 1639-51. 18. Montivani R, Mikuz G, Algaba F i wsp.: Epithelial tumors of the adult kidney. Virchows Arch 1999; 434: 281-90. 19. Delahunt B: Histopathologic prognostic indicators for renal cell carcinoma. Seminars in Diagnostic Pathology 1998; 15: 68-76. 20. Flocks RH, Kadesky MC: Malignant neoplasmas of the kidney. An analysis of 353 patients followed five years or more. J Urol 1958; 79: 196-201. 21. Robson CJ: Radical nephrectomy for renal cell carcinoma. J Urol 1963; 89: 37-42. 22. Delahunt B, Nancey JN: Renal cell carcinoma. Histological indicators of prognosis. Pathology 1987; 19: 258-63. 23. Storkel B, Thoenes W, Jacobi GH: Prognostic parameters in renal cell carcinoma – a new approach. Eur Urol 1989; 16: 416-22. 24. Sella A, Logothetis CJ, Ro JY: Sarcomatoid renal cell carcinoma. A treatable entity. Cancer 1987; 60: 1313-18. 25. Medeiros LJ, Michie SA, Johnson DE: An immunoperoxidase study of renal cell carcinomas. Pracę nadesłano: 17.12.2001 r. Adres autora: 92-216 Łódź, ul. Czechosłowacka 8/10
453
Correlation with nuclear grade, cell type, and histologic pattern. Hum Pathol 1988; 19: 980-87. 26. Burgal G: Interpretation of proliferation markers. Virchows Arch 1995; 427: 323341. 27. Gelb AB: Renal Cell Carcinoma. Current Prognostic Factors. Cancer 1997; 80: 981-86. 28. Grignon DJ, Ayala DG, El-Nagger A: Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases. Cancer 1989; 64: 213340. 29. Delahunt B, Bethwaite PB, Thornton A: Proliferation of renal cell carcinoma assessed by fixationresistent polyclonal Ki-67 antibody labelling: Corelation with clinical outcome. Cancer 1995; 75: 271419. 30. Cronin KJ, William NN, Kerin MJ: Proliferating cell nuclear antigen. A new prognostic indicator in renal cell carcinoma. J Urol 1994; 152: 83436. 31. Pepe S, Ruggiero A, d’Acquisto M i wsp.: Nuclear DNA Content Derived Parameters Correlated with Heterogenous Expression of p53 and bcl-2 Proteins in Clear Cell Renal Carcinoma. Cancer 2000; 89: 1065-75. 32. Uhlman DL, Nguyen PL, Manival JC: Association of immunohistochemical staining for p53 with metastatic progression and poor survival patients with renal cell carcinoma. J Natl Cancer Inst 1994; 86: 1470-75. 33. Ljunberg B, Bozoky B, Kovacs G i wsp.: p53 Expression in Correlation to Clinical Outcom in Patients with Renal Cell Carcinoma. Scand J Urol Nephrol 2001; 35: 15-20. 34. Bot FJ, Godschalk JCJ, Krishnadath KK: Prognostic factors in renal cell carcinoma. Immunohistochemical detection of p53 protein versus clinicopathological parameters. Int J Cancer 1994; 157: 634-37.